Skip to content
Affleck Greene McMurtry LLP | Barristers
Vik Tenekjian

Vik Tenekjian

Vik Tenekjian

Vik is a seasoned litigator with a focus on intellectual property (IP) enforcement and litigation, particularly for leading companies and trade associations in the technology and software sectors including Microsoft Corporation,  Autodesk Inc., and the Business Software Alliance (BSA).

Vik’s litigation practice encompasses a wide range of areas from contractual and licensing disputes to copyright and trademark litigation to patent litigation – in that regard, Vik has considerable experience in pharmaceutical patent litigation and has most recently also represented clients in several high-profile oil and gas patent litigation cases. Vik’s extensive courtroom experience spans both the Federal Court and the Federal Court of Appeal, where he has successfully handled a diverse array of high-stakes cases, as well as the Supreme Court of British Columbia.

Academically, Vik consistently excelled, graduating in 2001 with Honours from both McGill University (B.Sc.) and then Osgoode Hall Law School (J.D.). He has received numerous academic accolades, and, at just 21, earned distinction as one of the youngest first-authors of an international peer-reviewed publication in Protein Science.

Outside of his legal practice, Vik is an avid polyglot and traveler with a passion for exploring the world – having visited over 45 countries – and enjoys activities such as surfing, hiking, and, on occasion, surviving plane crashes.

‍*Practicing as Tenekjian Professional Corporation

Practice Areas

  • Corporate and Commercial Litigation

Other Practice Areas

Show More Practice Areas
  • Breach of Confidence
  • Intellectual Property
  • Intellectual Property Disputes

Experience

  • Partner, Gilbert's LLP, 2013-2026
  • Associate, Smart & Biggar LP, 2010-2013
  • Associate, Gowling WLG, 2006-2010
  • Trademark Agent, 2007
  • Called to the Bar, Ontario, 2006
  • Articling Student, Gowling WLG, 2005-2006

Education

  • JD (2005), Osgoode Hall Law School
  • BSc, Maj. Microbiology & Immunology, Min. Hispanic Studies (Hons. With Distinction) (2001), McGill University

Credentials

"Immunochemical evidence that cholesteryl ester transfer protein and bactericidal/permeability-increasing protein share a similar tertiary structure"
Protein Science, 8, pp. 2392–2398, doi:10.1110/ps.8.11.2392, 1999.

"The Same But Different: Patent Linkage in Canada"
LMG Life Sciences, 2, p. 153.

Selected Cases

Steelhead LNG (ASLNG) Ltd. v. ARC Resources Ltd., 2024 FCA 212

Steelhead LNG (ASLNG) Ltd. v. ARC Resources Ltd., 2024 FCA 212
Represented appellants on patent validity appeal. Cited as one of the top 10 Canadian business decisions of 2024–2025 by Lexpert. (canlii.org)

Steelhead LNG (ASLNG) Ltd. v. Arc Resources Ltd., 2024 FCA 67

Steelhead LNG (ASLNG) Ltd. v. ARC Resources Ltd., 2024 FCA 67
Acted in an appeal challenging the Federal Court's finding of non-infringement based on the definition of "use" under section 42 of the Patent Act. The Federal Court of Appeal upheld the trial court's interpretation of "use" (leave to the Supreme Court of Canada denied), in a landmark decision. (canlii.org)

Steelhead LNG (ASLNG) Ltd. v. ARC Resources Ltd., 2023 FC 1684

Steelhead LNG (ASLNG) Ltd. v. ARC Resources Ltd., 2023 FC 1684
Acted for the plaintiffs/defendants by counterclaim in a patent infringement action and counterclaim challenging the validity of Canadian Patent No. 3,027,085. (canlii.org)

Steelhead LNG (ASLNG) Ltd. v. ARC Resources Ltd., 2022 FC 998

Steelhead LNG (ASLNG) Ltd. v. ARC Resources Ltd., 2022 FC 998
Acted for the defendants in an infringement summary trial of a patent infringement action related to a patented floating liquefied natural gas (FLNG) facility. (canlii.org)

Microsoft Corporation v. Liu, 2016 FC 950

Microsoft Corporation v. Liu, 2016 FC 950
Acted for the plaintiff Microsoft Corporation in a copyright infringement action involving the unauthorized sale of counterfeit software. The Court found in favour of Microsoft and awarded statutory damages and a permanent injunction. (canlii.org)

AstraZeneca Canada Inc. v. Apotex Inc., 2013 FCA 47

AstraZeneca Canada Inc. v. Apotex Inc., 2013 FCA 47
Acted for the respondent AstraZeneca in an appeal under the Patented Medicines (Notice of Compliance) Regulations concerning the validity of a pharmaceutical patent. The Federal Court of Appeal upheld the decision in AstraZeneca's favour. (canlii.org)

AstraZeneca Canada Inc. v. Ranbaxy Pharmaceuticals Canada Inc., 2013 FC 232

AstraZeneca Canada Inc. v. Ranbaxy Pharmaceuticals Canada Inc., 2013 FC 232
Acted for the applicant AstraZeneca in a proceeding under the Patented Medicines (Notice of Compliance) Regulations. The Court rejected Ranbaxy's allegation that AstraZeneca's patent was invalid for obviousness. (canlii.org)

Adobe Systems Incorporated et al v. Dale Thompson, 2012 FC 1219

Adobe Systems Incorporated v. Dale Thompson, 2012 FC 1219
Acted for the plaintiff Adobe Systems in a copyright infringement action involving the unauthorized distribution of counterfeit software. The Court granted judgment in favour of Adobe, awarding damages and injunctive relief. (canlii.org)

AstraZeneca Canada Inc. v. Pharmascience Inc., 2012 FC 1189

AstraZeneca Canada Inc. v. Pharmascience Inc., 2012 FC 1189
Acted for the successful applicant AstraZeneca in a proceeding under the Patented Medicines (Notice of Compliance) Regulations, successfully defending a pharmaceutical patent against an allegation of invalidity. (canlii.org)

AstraZeneca Canada Inc v. Apotex Inc, 2012 FC 991

Acted for AstraZeneca in Federal Court pharmaceutical patent proceedings involving litigation concerning AstraZeneca's esomeprazole product line against generic manufacturer Apotex.

AstraZeneca Canada Inc. and AstraZeneca AB v. Mylan Pharmaceuticals ULC and Minister of Health, T-134-10 (Federal Court), April 2010 (unpublished)
Abbott Laboratories Ltd. v. Canada (Health), 2008 FC 919

Abbott Laboratories Ltd. v. Canada (Health), 2008 FC 919
Acted for the respondent Takeda Pharmaceutical Company Limited in a proceeding under the Patented Medicines (Notice of Compliance) Regulations. (canlii.org)

AstraZeneca Canada Inc. v. Apotex Inc., 2008 FC 537

AstraZeneca Canada Inc. v. Apotex Inc., 2008 FC 537
Acted for the respondent Takeda Pharmaceutical Company Limited in a proceeding under the Patented Medicines (Notice of Compliance) Regulations. (canlii.org)

Abbott Laboratories Ltd. v. Canada (Health), 2007 FC 865

Abbott Laboratories Ltd. v. Canada (Health), 2007 FC 865
Acted for the respondent Takeda Pharmaceutical Company Limited in a proceeding under the Patented Medicines (Notice of Compliance) Regulations. (canlii.org)

Novopharm Ltd. v. Abbott Laboratories Ltd., 2007 FCA 251

Novopharm Ltd. v. Abbott Laboratories Ltd., 2007 FCA 251
Acted for the respondent Takeda Pharmaceutical Company Limited in an appeal under the Patented Medicines (Notice of Compliance) Regulations before the Federal Court of Appeal. (canlii.org)

Eli Lilly Canada Inc. v. Novopharm Ltd., 2006 FC 1278

Eli Lilly Canada Inc. v. Novopharm Ltd., 2006 FC 1278
Acted for the respondent Takeda Pharmaceutical Company Limited in a proceeding under the Patented Medicines (Notice of Compliance) Regulations. (canlii.org)

Calgon Carbon Corporation v. North Bay (City), 2006 FC 1373

Calgon Carbon Corporation v. North Bay (City), 2006 FC 1373
Acted for the defendant City of North Bay in a patent infringement action. Successfully defended the municipality against the plaintiff's claims. (canlii.org)

WHAT OTHERS SAY ABOUT US